Christos Agalianos1, Nikolaos Gouvas2, Kleo Papaparaskeva3, Christos Dervenis2. 1. Athens Naval and Veterans Hospital, Department of Surgery, Athens, Greece. Electronic address: xagali@gmail.com. 2. "Konstantopouleio" Hospital of Athens, Department of Surgery, Athens, Greece. 3. "Konstantopouleio" Hospital of Athens, Department of Pathology, Athens, Greece.
Abstract
BACKGROUND: The relation between para-aortic lymph nodes (PALN) involvement and pancreatic ductal adenocarcinoma (PDAC) survival, along with the optimal handling of this particular lymph node station remain unclear. A systematic review and meta-analysis was performed to assess this. METHODS: A search of Medline, Embase, Ovid and Cochrane databases was performed until July 2015 to identify studies reporting on the relation of PALN involvement and PDAC outcomes and a meta-analysis was performed following data extraction. RESULTS: Ten retrospective studies and two prospective non randomized studies (2467 patients) were included. Patients with positive PALN had worse one (p < 0.00001) and two year (p < 0.00001) survival when compared with patients with negative PALN. Even when comparing only patients with positive lymph nodes (N1), patients with PALN involvement presented with a significant lower one (p = 0.03) and two (p = 0.002) year survival. PALN involvement was associated with an increased possibility of positive margin (R1) resection (p < 0.00001), stations' 12, 14 and 17 malignant infiltration (p < 0.00001), but not with tumour stage (p = 0.78). DISCUSSION: Involvement of PALN is associated with decreased survival in pancreatic cancer patients. However, existence of long term survivors among this subgroup of patients should be further evaluated, in order to identify factors associated with their favourable prognosis.
BACKGROUND: The relation between para-aortic lymph nodes (PALN) involvement and pancreatic ductal adenocarcinoma (PDAC) survival, along with the optimal handling of this particular lymph node station remain unclear. A systematic review and meta-analysis was performed to assess this. METHODS: A search of Medline, Embase, Ovid and Cochrane databases was performed until July 2015 to identify studies reporting on the relation of PALN involvement and PDAC outcomes and a meta-analysis was performed following data extraction. RESULTS: Ten retrospective studies and two prospective non randomized studies (2467 patients) were included. Patients with positive PALN had worse one (p < 0.00001) and two year (p < 0.00001) survival when compared with patients with negative PALN. Even when comparing only patients with positive lymph nodes (N1), patients with PALN involvement presented with a significant lower one (p = 0.03) and two (p = 0.002) year survival. PALN involvement was associated with an increased possibility of positive margin (R1) resection (p < 0.00001), stations' 12, 14 and 17 malignant infiltration (p < 0.00001), but not with tumour stage (p = 0.78). DISCUSSION: Involvement of PALN is associated with decreased survival in pancreatic cancerpatients. However, existence of long term survivors among this subgroup of patients should be further evaluated, in order to identify factors associated with their favourable prognosis.
Authors: Shailesh V Shrikhande; Jörg Kleeff; Carolin Reiser; Jürgen Weitz; Ulf Hinz; Irene Esposito; Jan Schmidt; Helmut Friess; Markus W Büchler Journal: Ann Surg Oncol Date: 2006-10-25 Impact factor: 5.344
Authors: Giuseppe Malleo; Laura Maggino; Paola Capelli; Francesco Gulino; Silvia Segattini; Aldo Scarpa; Claudio Bassi; Giovanni Butturini; Roberto Salvia Journal: J Am Coll Surg Date: 2015-02-28 Impact factor: 6.113
Authors: Rupaly Pande; Shafiq Chughtai; Manish Ahuja; Rachel Brown; David C Bartlett; Bobby V Dasari; Ravi Marudanayagam; Darius Mirza; Keith Roberts; John Isaac; Robert P Sutcliffe; Nikolaos A Chatzizacharias Journal: World J Gastrointest Surg Date: 2022-05-27
Authors: Eline Soer; Lodewijk Brosens; Marc van de Vijver; Frederike Dijk; Marie-Louise van Velthuysen; Arantza Farina-Sarasqueta; Hans Morreau; Johan Offerhaus; Lianne Koens; Joanne Verheij Journal: Virchows Arch Date: 2018-03-27 Impact factor: 4.064